scholarly article | Q13442814 |
P2093 | author name string | J G R De Mey | |
M G Compeer | |||
G M J Janssen | |||
P2860 | cites work | The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes | Q24339000 |
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential | Q24656131 | ||
International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature | Q28201563 | ||
Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils | Q28308243 | ||
Evidence that ET-1, but not ET-3 and S6b, ET(A)-receptor mediated contractions in isolated rat mesenteric arteries are modulated by co-activation of ET(B) receptors | Q28343934 | ||
Calcitonin gene-related peptide selectively relaxes contractile responses to endothelin-1 in rat mesenteric resistance arteries | Q28581000 | ||
A novel potent vasoconstrictor peptide produced by vascular endothelial cells | Q29620540 | ||
Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. | Q30304611 | ||
NO-independent regulatory site on soluble guanylate cyclase | Q32165040 | ||
Vascular biology of endothelin signal transduction | Q33538208 | ||
Stimuli of sensory-motor nerves terminate arterial contractile effects of endothelin-1 by CGRP and dissociation of ET-1/ET(A)-receptor complexes | Q33598651 | ||
Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. | Q33675630 | ||
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery | Q33890786 | ||
Protein kinase C-induced phosphorylation of Orai1 regulates the intracellular Ca2+ level via the store-operated Ca2+ channel. | Q34055973 | ||
Animal research: reporting in vivo experiments: the ARRIVE guidelines | Q34116755 | ||
Evidence for separate effects of U73122 on phospholipase C and calcium channels in human platelets | Q77596611 | ||
Novel mechanism of endothelin-1-induced vasospasm after subarachnoid hemorrhage | Q80058632 | ||
Endothelin-1 and -2: two amino acids matter | Q83618517 | ||
Calcitonin gene-related peptide terminates long-lasting vasopressor responses to endothelin 1 in vivo | Q84179242 | ||
Direct activation of human phospholipase C by its well known inhibitor u73122. | Q34160786 | ||
Guide to Receptors and Channels (GRAC), 5th edition | Q34228968 | ||
Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways | Q34565134 | ||
Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve? | Q34660839 | ||
Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme | Q34720361 | ||
Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound | Q34963488 | ||
Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells | Q35372931 | ||
Historical review: Endothelin | Q35737648 | ||
G-protein-coupled receptor allosterism: the promise and the problem(s). | Q35922941 | ||
G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide | Q36153281 | ||
Rho kinases in cardiovascular physiology and pathophysiology | Q36399309 | ||
The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? | Q36510011 | ||
Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer. | Q36610315 | ||
Phospholipase C-delta1 modulates sustained contraction of rat mesenteric small arteries in response to noradrenaline, but not endothelin-1 | Q36844595 | ||
Endothelin receptors and pain | Q37070713 | ||
Vascular Smooth Muscle Cell Signaling Mechanisms for Contraction to Angiotensin II and Endothelin-1. | Q37247141 | ||
On the potential role of source and species of diacylglycerol in phospholipase-dependent regulation of TRPC3 channels | Q37748394 | ||
Allosteric modulation of G protein-coupled receptors: a pharmacological perspective. | Q37773544 | ||
Pharmacological modulation of diacylglycerol-sensitive TRPC3/6/7 channels | Q37798861 | ||
Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca(2+) entry pathways | Q39302766 | ||
Assessment of endothelin-A receptor expression in subcutaneous and orthotopic thyroid carcinoma xenografts in vivo employing optical imaging methods. | Q39363342 | ||
Guidelines for reporting experiments involving animals: the ARRIVE guidelines | Q39512979 | ||
ETA-receptor antagonists or allosteric modulators? | Q39761886 | ||
Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells | Q40304029 | ||
Activation of native TRPC1/C5/C6 channels by endothelin-1 is mediated by both PIP3 and PIP2 in rabbit coronary artery myocytes | Q41864077 | ||
Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery | Q41867528 | ||
Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2. | Q41906789 | ||
Agonist-dependent modulation of arterial endothelinA receptor function | Q42246404 | ||
Involvement of rho-kinase in agonists-induced contractions of arteriosclerotic human arteries. | Q43880565 | ||
Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit | Q44050284 | ||
NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. | Q45205014 | ||
The quasi-irreversible nature of endothelin binding and G protein-linked signaling in cardiac myocytes. | Q46668488 | ||
Functional antagonism between endogenous neuropeptide Y and calcitonin gene-related peptide in mesenteric resistance arteries | Q46868861 | ||
Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP. | Q47324962 | ||
The vasoconstriction induced by endothelin-1 is mediated only by ET(A) receptors in mesenteric small resistance arteries of spontaneously hypertensive rats and Wistar Kyoto rats. | Q54145893 | ||
Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation. | Q54273171 | ||
G-proteins are involved in contractile responses of isolated mesenteric resistance arteries to agonists. | Q54315038 | ||
Pinacidil, a new vasodilator: pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension | Q71142508 | ||
Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery | Q71606785 | ||
Felodipine, an arteriolar dilator with pronounced antihypertensive effect | Q72544670 | ||
Cardiovascular effects of sympathomimetic bronchodilators; epinephrine, ephedrine, pseudoephedrine, isoproterenol, methoxyphenamine and isoprophenamine | Q77151835 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1199-1209 | |
P577 | publication date | 2013-11-01 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries | |
P478 | volume | 170 |
Q92909708 | Dissecting genetic factors affecting phenylephrine infusion rates during anesthesia: a genome-wide association study employing EHR data |
Q26767156 | Endothelin |
Q52950195 | Endothelin-1 and Endothelin-3 Regulate Endothelin Receptor Expression in Rat Coronary Arteries. |
Q28246158 | Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12 |
Q38742466 | Evidence for biased agonists and antagonists at the endothelin receptors |
Search more.